The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk stratification and age-related disparities with abemaciclib responses in early ER-positive/HER2-negative breast cancer.
 
Masanori Oshi
No Relationships to Disclose
 
Adrienne Groman
No Relationships to Disclose
 
Takako Kuroda
No Relationships to Disclose
 
Takuho Okamura
No Relationships to Disclose
 
Aya Nishikawa
No Relationships to Disclose
 
Shipra Gandhi
Honoraria - Aptitude Health; Clinical Care Options; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Genentech; Hologic/Biotheranostics; MedPage Today; Novartis; Peerview; Stemline Therapeutics
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MJH Life Sciences; Roche
 
Akimitsu Yamada
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Exact Sciences; Kyowa Kirin International; Lilly Japan; Medicon; MSD; Nipro Corporation; Pfizer; Takeda
 
Kazutaka Narui
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; Pfizer; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly Japan (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Itaru Endo
No Relationships to Disclose
 
Kazuaki Takabe
No Relationships to Disclose
 
Takafumi Sangai
Honoraria - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Exact Sciences; Gilead Sciences; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; PDRadiopharma; Pfizer
Research Funding - Chugai Pharma; Kyowa Kirin International